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presence of carnosol in SC and NSC cultures and highly reduced in both
cell cultures in presence of rosemary extract.Carnosol was able to reduce
IL-6 production by both SC and NSC osteoblasts at all doses tested while
rosemary extract was eﬃcient only on osteoblasts from the NSC area. Both
compounds were also able to signiﬁcantly decrease PGE2 production by
osteoblasts from both subchondral areas.
In the coculture experiments, carnosol pre-incubated in NSC and SC os-
teoblasts signiﬁcantly increased AGG and signiﬁcantly decreased MMP-3
and OPN gene expression by chondrocytes. Rosemary extract only signif-
icantly decreased MMP-3 expression by chondrocytes in presence of SC
osteoblasts.
Conclusions: In our experimental conditions, we showed that carnosol,
through anti-inﬂammatory mechanisms, was able to reduce cartilage
matrix breakdown and enhance its formation, more consistently than
rosemary extract, at physiological concentrations.
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MESENCHYMAL STEM CELLS IN OA PATIENTS: DOWNREGULATION OF
WNT SIGNALING PATHWAY AND MIR335
B. Fernandez-Gutierrez1 , E. Villafuertes1, J. Hoyas1, M. Gonzalez2,
P. Tornero-Esteban1
1Hosp. Clinico San Carlos, Madrid, Spain; 2CNIC, Madrid, Spain
Purpose: Osteoarthritis (OA) is a disease characterized by progressive
degeneration of articular cartilage and bone. Homeostasis of the articular
tissues depends largely on the ability of self-renewal and differentiation
of mesenchymal stem cells (MSCs) into different cell types of mesodermal
lineage. This process is mediated by activation and suppression of differ-
ent genes controlling post-transcriptional regulation of gene expression.
miRNAs (short 20-24 nt non-coding RNAs) are key molecules affecting
both the stability and translation of mRNAs. The expression of miR335
in control Bone Marrow-MSCs (BM-MSCs) has been previously connected
with the canonical Wnt signaling pathway. According to these evidences,
our purpose is to study, in BM-MSCs from OA patients, the canonical Wnt
pathway and the expression of miR335.
Methods: Eight OA patients and eight controls were included. BM-MSCs
from OA patients were obtained at the time of total joint replacement
surgery of hip OA. BM-MSCs from controls were obtained at the time
of surgery of subcapital hip fracture without OA signs and without
osteoporosis.
Cells were isolated and expanded until the third passage. RNAs were ex-
tracted to perform comparative gene expression proﬁling using the Agilent
4×44 whole-genome expression array and the Agilent Human microRNA.
After data ﬁltering, background correction and, normalization, differentially
expressed genes at p<0.05 level of signiﬁcance showing more than, or less
than, two-fold differences, were eligible. To determine miRNA expressions,
RNA samples from ﬁve patients and ﬁve controls were hibridized and
analyzed using the Microarray v2.0 (G4470B, Agilent). MEST gene, that con-
trols miR335 expression, was analyzed in the Agilent 4×44 whole-genome
expression array and validated by quantitative PCR (qPCR).
Results: Wnt pathway was clearly defective in MSCs from OA origin. Major
differences showed a signiﬁcant downregulation of 11 genes related to the
Wnt pathway, these include CCND2, CSNK2A1, DVL1, DVL3, FZD3, LRP6,
NLK, PPP3CC, SENP2, SFRP2 and WNT4. In addition, in all samples miR335
expression levels were diminished around 50% in OA patients compared to
expression levels found in controls.
MEST gene was clearly downregulated in the Agilent 4×44 whole-genome
expression array and this result is concordant with MEST qPCR results.
Conclusions: Our results suggest that expression of miR335 in MSCs is
connected with Wnt signaling pathway also in OA patients. We hypothesize
that the diminished miR335 expression and Wnt signalling pathway in OA
could be a part of the altered function of BM-MSCs in OA patients.
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MIR-7 ANDMIR-130B ARE DIFFERENTIALLY REGULATED DURING
MESENCHYMAL STEM CELL COMMITMENT
G. Palmer1, L. Danielson2, M. Attur1, S.B. Abramson1, E. Hernando2
1NYUHosp. for Joint Diseases, New York, NY; 2NYU Langone Med. Ctr., New
York, NY
Purpose: Stem cell-based therapies aimed at introducing progenitor cells
into cartilage lesions hold great promise for the restoration of damaged
articular surfaces following joint injury or osteoarthritis. Key to the gen-
eration of a functional repair tissue is the controlled differentiation into
the desired phenotype. To this end microRNAs (miRNAs) may be important
molecules that regulate this process. By acting as transcriptional repressors,
their modulation during differentiation may enable commitment to a spe-
ciﬁc lineage by suppressing the expression of other lineage markers. In this
study we proﬁled Mesenchymal Stem Cells (MSCs) for miRNA expression
following induction into the chondrocyte (C), osteoblast (O) and smooth
muscle (SM) lineages.
Methods: Cell culture: Human bone marrow derived MSCs were obtained
from NIH or from the discarded hips of patients undergoing joint replace-
ment surgery. Differentiation: SM differentiation was induced by treating
monolayer cultures with 1 μM thromboxane-A2 [DP1] in the presence of
0.25% serum. C differentiation was induced by seeding MSCs in aggregate
cultures in the presence of 1% ITS, dexamethasone (10-7 M) and TGF-β1
(10 ng/ml). O differentiation was induced by treatment of monolayer
cultures with dexamethasone (10-7 M), ascorbate (37.5 μg/ml) and beta-
glycerolphosphate (10 mM) in the presence of 10% serum. miRNA proﬁling:
At various timepoints after induction, miRNA was extracted for analysis.
miRNA proﬁling was performed by microarray (Agilent) or qPCR based
assay (SA Biosciences). In all cases differentiation was conﬁrmed by qPCR
of lineage speciﬁc markers and histology.
Results: Among 376 miRNA probes, we noted differential regulation of
two miRNAs among O, SM and C lineages. Following SM and C dif-
ferentiation, miR-7 expression was down-regulated up to 6.9-fold and
3-fold respectively. Conversely, during O differentiation, its expression was
induced approximately 7-fold. Analysis of theoretical mRNA targets us-
ing TargetScan online software (www.targetscan.org) identiﬁed conserved
sites in several genes associated with chondrocyte and myoblast lineages.
Putative chondrogenic targets were found to include COL2A1, IGFR1, and
GDF5, while potential smooth muscle modulators included EGFR1, PIK3CD,
IRS1/IRS2, KLF4, CNN3 and IGF1R. Following a similar trend to miR-7,
miR-130b was down-regulated up to 3.2-fold and 3.1-fold in C and SM
differentiation respectively, while O differentiation induced its expression
2-fold. TargetScan analysis identiﬁed putative chondrogenic targets, TGF-
BRII, Sox5, BMP-2 and IGF1; Potential smooth muscle regulators included
ESR1, TGF-BRII, MBLN1, TGFBR1 and IGF2BP1. Together these observations
suggest that miR-7 and miR-130b act to negatively regulate myogenic and
chondrogenic cell fates via regulation of lineage speciﬁc genes.
Conclusion: Our ﬁndings suggest that miR-7 and miR-130b, via the target-
ing of lineage speciﬁc molecules, regulate cell fate in adult human MSCs
by inhibiting smooth muscle and chondrocyte differentiation, thereby
promoting ‘default’ differentiation into the osteoblast lineage.
[DP1]0.25% FBS 24 hours prior to addition of 1.0μM of the TxA2 chemical
analog U46619
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BOVINE PRIMARY CHONDROCYTES STIMULATE CARTILAGINOUSMATRIX
PRODUCTION BY HUMAN EMBRYONIC STEM CELLS
N. Ahmed1,2, D.W. Taylor1,2, G. Keller3, M.D. Grynpas1,2, R. Kandel1,2
1Mount Sinai Hosp., Toronto, ON, Canada; 2CIHR-BioEngineering of Skeletal
Tissues Team, Toronto, ON, Canada; 3McEwen Ctr. for Regenerative Med., Univ.
Hlth.Network, Univ. of Toronto, Toronto, ON, Canada
Purpose: A requirement of in vitro tissue generation for cartilage repair is
suﬃcient number of cells which is diﬃcult to attain from sparsely cellular
cartilage tissue. Thus proper selection of cell source is an impending
problem for cartilage tissue engineering. Optional cell types are chondro-
cytes, marrow progenitor cells and embryonic stem cells. Use of human
embryonic stem cells (hES) for cartilage tissue engineering is still in its
infancy mainly because the existing techniques do not render functionally
stable cartilage tissue. To push hES cells towards a speciﬁc lineage cues
are required from growth factors, media and culture conditions. Previ-
ously we have shown that co-culture of dedifferentiated chondrocytes
with small numbers of primary chondrocytes induces redifferentiation
in passaged dedifferentiated cells. In this study we show for the ﬁrst
time a novel culture approach where hES cells when co-cultured with
bovine primary chondrocytes (bP0) exhibit the ability to deposit functional
three-dimensional cartilaginous matrix.
Methods: Cell preparation: Bovine articular cartilage (6-9 months old)
was harvested from metacarpo-phalangeal joints and chondrocytes were
isolated by sequential enzymatic digestion. GFP labeled-human embryonic
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stem cell line (GFP-hES2) was cultured in DMEM/F-12 containing 20%
serum replacement, 10% mouse embryonic ﬁbroblast conditioned media
and β-Mercaptoethanol on gelatin-coated plates seeded with irradiated
mouse feeder cells. Chondrogenic differentiation: We developed a novel two
step protocol for chondrogenic differentiation of GFP-hES2. 1. Mesoderm
differentiation: Embryoid bodies were developed in lo-cluster tissue culture
plates in the presence of BMP4, bFGF, and Act-A. 2. Chondrogenesis: The
second step was co-culture of the mesodermal cells with primary bovine
chondrocytes (bP0). bP0 and GFP-hES2 were mixed at a ratio of 1:4 and
co-cultured on Millicell™ membrane inserts, which allow for 3D growth,
in DMEM supplemented with 20%FBS. After 4 weeks the newly formed
tissue was characterized and compared with tissue formed by bP0 and
hES2 alone. Analysis: FACS analysis of the GFP-hES2 cells was carried out
using selected antibodies. Histological qualitative assessment of the newly
formed tissue was done by using light microscopy and toluidine blue
staining. Proteoglycan accumulation was semi-quantitatively determined
by dimethylmethylene blue dye-binding assay. Values were normalized to
total DNA content determined by Hoechst 33258 dye binding assay. Gene
expression was quantiﬁed by qPCR. Statistics: Results were expressed as
mean ± SD of 3 independent experiments and signiﬁcance determined by
one-way ANOVA.
Results: FACS analysis after the ﬁrst stage of culture at day 5 showed that
only 5-7% of cells remained positive for ckit, an embryonic stem cell marker,
indicating a shift towards more differentiated state. Furthermore, 50-60%
of the cells were KDR and PDGF double positive, indicating that these cells
attained mesodermal features. At this stage cells were co-cultured with
bP0. After 4 weeks GFP-hES2 appeared to be present and surrounded by
newly deposited cartilaginous matrix when visualized under ﬂuorescent
microscopy. Toluidine blue staining and dimethylmethylene blue assay
showed that the proteoglycan content of tissue formed by co-cultured em-
bryonic stem cells at 4 weeks was signiﬁcantly higher than tissue formed
by the bovine chondrocytes alone. qPCR showed higher gene expression
of type II collagen, aggrecan, and SOX9. GFP-hES2 cultured alone failed to
accumulate any cartilaginous matrix.
Conclusions: We conclude that bovine primary chondrocytes produce
factors which promote chondrogenic differentiation of partially differenti-
ated embryonic stem cells. Understanding the mechanism regulating this
differentiation may aid in developing a source of cells suitable to use for
cartilage repair.
Acknowledgement: Supported by CIHR.
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OSTEOARTHRITIS PATIENTS’ PERCEPTIONS REGARDING
APPROPRIATENESS FOR TOTAL JOINT REPLACEMENT SURGERY
G. Hawker1, L. Frankel1, L. Freeman-Collins2, D. Marshall3,
B. Conner-Spady3, C. SanMartin4
1Univ. of Toronto, Toronto, ON, Canada; 2Women’s Coll. Hosp., Toronto, ON,
Canada; 3Univ. of Calgary, Calgary, AB, Canada; 4Statistics Canada, Ottawa,
ON, Canada
Purpose: Appropriateness criteria for hip/knee total joint replacement (TJR)
have been based on expert physician opinion and, in general, consider
three groups of patient factors: disease severity (pain and functioning, ra-
diographs), capacity to beneﬁt, and willingness (motivation). The objective
of our study was to gain an understanding of patients’ perspectives on
appropriateness for TJR, including if, and how, appropriateness relates to
willingness to undergo this surgery.
Methods: Focus groups were conducted in English-speaking individu-
als considered good candidates for TJR (WOMAC score ≥ 30/100, x-ray
hip/knee osteoarthritis (OA), no surgical contraindications) with and with-
out a prior TJR. Participants were recruited from the community and
existing OA cohorts to ensure representation of men and women, urban
and rural residents, and ages 40-64 and 65+ years. Focus group questions
were directed at understanding participants’ perceptions of their own
appropriateness for TJR and appropriateness for TJR more broadly, and the
relationship, if any, between appropriateness and willingness. Following
the discussion, participants completed a standardized questionnaire as-
sessing socio-demographics, arthritis severity (WOMAC), and willingness to
consider, and perceived candidacy for, TJR (5-point scales from deﬁnitely no
to deﬁnitely yes). Focus groups were audio-taped and the tapes transcribed
verbatim by a single transcriber. Transcripts were reviewed independently
by two researchers to identify distinct themes. Themes were compared and
consensus reached.
Results: 11 focus groups were conducted in 58 individuals (36 with a prior
TJR); mean age was 72 years, 79% were female and 49% had ≤ high school
education. Mean symptom duration was 17.5 years. The mean WOMAC
summary score was 43.1 (SD 19.8); 50% were willing to consider TJR
(75% with and 36% without a prior TJR) and 43% considered themselves
appropriate for TJR. Appropriateness for TJR was equated with ‘candidacy’
for the surgery. Pain intensity, and ability to cope with the pain, was
identiﬁed as the most important factor determining surgical candidacy,
yet participants felt pain was inadequately considered and evaluated by
physicians. TJR candidacy was also linked to the balance of risks and
beneﬁts, including the impact on employment, independence, and burden
on/ability to care for others, their physician’s opinion, and comparisons
with others who had/had not undergone TJR. Availability of social support
and a ‘positive outlook’ (motivation to comply with post-operative rehab)
were identiﬁed as key to TJR success, and thus important to consider in
assessing appropriateness. Considering these factors, age and weight were
felt to be unimportant. Appropriateness and willingness were considered
as distinct, yet related, concepts. Participants noted that an individual may
feel they are a good surgical candidate, yet be unwilling to consider TJR for
other reasons, e.g. care giving responsibilities. However, willingness played
an important role in determining patients’ sense of appropriateness such
that those who were unwilling to consider TJR had stricter rules regarding
TJR candidacy than their willing counterparts, seeing TJR as a treatment
only for extremes of pain and disability.
Conclusion: Consistent with surgeons, people with hip/knee OA identiﬁed
arthritis severity, motivation or willingness, and capacity to beneﬁt (risks
versus beneﬁts) as key considerations in determining appropriateness for
TJR. The patients’ pain experience (impact, ability to cope) was seen as
the most important determinant, but inadequately considered by clinicians.
Enhanced patient-physician communication to better elaborate the OA pain
experience, possibly through use of more comprehensive and standardized
pain assessment tools, has potential to improve timely access to TJR by
those who may beneﬁt.
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FOURTEEN YEAR RISK OF REVISION FOLLOWING PRIMARY TOTAL HIP
REPLACEMENT PERFORMED IN A US POPULATION BASED SAMPLE
J.N. Katz1,2, E.A. Wright1,2, A.A. Nti1, J. Wright1,2, E. Losina1,2
1Brigham and Women’s Hosp., Boston, MA; 2Harvard Med. Sch., Boston, MA
Purpose: There have been no prior US national population-based studies of
the risk of revision following primary total hip replacement (THR) with 14
year follow up and complete ascertainment of revision and mortality. Prior
population based studies are limited by substantially incomplete follow-up.
It is important to understand the risk of revision among patients undergo-
ing primary THR in order to set appropriate expectations for patients and
to accurately forecast resource needs.
Methods: We used Medicare claims data to assemble a cohort of 58,521
patients aged ≥65 who had primary THR in 1995-96. We followed this
cohort by assessing their Medicare claims through 2008. We determined
the 14 year risk of revision in each cohort, for men and women, using the
Kaplan Meier (KM) method. We compared the risk of revision with the risk
of mortality over the 14 year time frame. We display these data in two
cohorts stratiﬁed by age at the time of primary THR: 65-75 and >75.
Results: The 65-75 year old cohort comprised 35,373 THR recipients and
the >75 cohort 23,148. 43% of the 65-75 cohort and 75% of the >75 cohort
died over 14 years of follow up. The Figures demonstrate the cumulative 14
year risk of revision THR (shown in the darker area on the Figures) and of
survival wihtout revision (shown in the lighter area). The two age groups
are presented in separate ﬁgures. Using the KM method, the cumulative 14
year revision risk in the 65-75 cohort was 14% (16% in males and 13% in
females), as compared with a revision risk of 9% in the >75 cohort (11%
in males and 8% in females) These differences in sex and age were both
statistically signiﬁcant at p<0.001.
Conclusions: In both age groups, particularly those >75, the risk of death
was substantially greater than the risk of revision. Revision risk is higher in
the 65-75 year old cohort than in those >75 and higher in males than in
females. These ﬁndings may reﬂect greater implant wear among males and
among younger patients; greater patient preference for proceeding with
revision surgery among younger patients and males who have syptomatic
loosening; and/or greater willingness among physicians to carry out revi-
sion surgery among younger patients. These ﬁndings are strengthened by
the complete ascertainment of revision and death over the timeframe of the
